Interview with Dr Mario Rocci (ICON) on incurred sample reanalysis and regulatory challenges

Mario Rocci (ICON, USA) spoke to Bioanalysis Zone in May 2011. What is your opinion on the current state of the pharmaceutical industry? The pharmaceutical industry is in a substantial state of flux. A significant number of blockbuster drugs will be losing patent protection within the next few years and pharmaceutical companies are hard at work trying to identify potential new drugs for development with mixed success. To help improve this success, the better part of this decade has been consumed with efforts to evolve pathways that translate basic research findings to the bedside quickly and efficiently. To further complicate the...